safety
Articles tagged with “safety”
Low Dose Ketamine Urinary Tract Long-Term Safety
What patients should know about low dose ketamine urinary tract long-term safety, including monitoring, warning signs, and questions to ask your prescriber.
Ketamine and Liver Function Tests: Monitoring LFTs During Therapy
A clinical guide to liver function test monitoring during low-dose ketamine therapy, including baseline assessment, frequency of testing, interpreting abnormal results, and managing hepatotoxicity risk.
Low-Dose Ketamine and Alcohol: Patient Safety Guide
A safety-focused guide on the risks and clinical considerations of alcohol use during ketamine therapy, covering pharmacological interactions, metabolism, timing guidelines, and patient counseling strategies.
Ketamine and Benzodiazepines: Clinical Interaction Guide
How do benzodiazepines affect low-dose ketamine response? Review of GABAergic blunting, pre-session timing, taper considerations, and clinical findings.
Ketamine and SSRIs: Drug Interaction Deep Dive
Can patients take SSRIs during low-dose ketamine therapy? Review of pharmacodynamic overlap, serotonin syndrome signals, and co-prescribing patterns.
Safety and Side Effects
Important information about the safety profile of low-dose ketamine therapy, including common side effects, serious risks, driving restrictions, and long-term considerations.
Can You Drive After Ketamine Treatment?
When is it safe to drive after a low-dose ketamine session? Review of dissociation timing, cognitive recovery windows, and clinic discharge guidance.
Is Ketamine Therapy Addictive?
When administered in a supervised clinical setting at low doses, ketamine therapy carries a low risk of addiction, though the drug does have abuse potential.
How Long Do Ketamine Side Effects Last?
Most ketamine side effects resolve within 1 to 2 hours after an infusion ends, with subtle residual effects fading within 4 to 6 hours.
Ketamine and Bladder Health: Urological Safety at Therapeutic Doses
Does low-dose ketamine cause bladder problems? Review of urological risk at therapeutic vs recreational doses, mechanisms, and monitoring recommendations.
Ketamine and Blood Pressure: What Patients Should Know
A patient-oriented clinical guide to understanding ketamine's effects on blood pressure, including why blood pressure rises during treatment, what levels are expected, who is at increased risk, and how clinicians manage cardiovascular responses.
Ketamine in Pregnancy and Lactation: Safety Considerations and Data Gaps
What do we know about low-dose ketamine in pregnancy and lactation? Review of safety data, placental transfer, breastfeeding considerations, and evidence gaps.
Abuse Potential of Therapeutic Ketamine: Risk Stratification and Monitoring
Assessment of abuse potential for therapeutic ketamine, examining risk stratification approaches, monitoring strategies, and safeguards for clinical prescribing programs.
Ketamine Side Effects: A Complete Clinical Guide
Comprehensive evidence-based review of ketamine side effects including dissociation, nausea, cardiovascular changes, and cognitive effects for clinicians.
Ketamine Tolerance and Long-Term Use: What Clinicians Need to Know
Clinical review of tolerance development during long-term ketamine therapy, including mechanisms, detection strategies, and evidence-based management approaches.
Managing Nausea and Vomiting During Ketamine Therapy
Clinical guide to preventing and treating ketamine-induced nausea and vomiting, covering antiemetic protocols, risk factors, and non-pharmacological strategies.
Cognitive Effects of Repeated Low-Dose Ketamine: Neuropsychological Assessment
Does repeated low-dose ketamine affect cognition? Review of memory, attention, and executive function testing across short- and longer-term treatment courses.
Ketamine-Associated Hepatotoxicity: Risk Factors and Liver Function Monitoring
Review of ketamine-associated hepatotoxicity including risk factors, proposed mechanisms, liver function monitoring protocols, and clinical management for repeated therapeutic dosing.
Cardiovascular Effects of Low-Dose Ketamine: Hemodynamic Monitoring Guidelines
Evidence-based hemodynamic monitoring guidelines for low-dose ketamine, covering sympathomimetic cardiovascular effects, blood pressure management, and cardiac risk stratification.
Long-Term Safety Considerations for Ketamine Therapy
What is known about long-term low-dose ketamine safety? Review of cumulative exposure data, organ-specific monitoring, and gaps in multi-year evidence.
Clinically Significant Drug Interactions with Low-Dose Ketamine
Which medications interact with low-dose ketamine? Review of CNS depressants, serotonergic drugs, CYP enzyme effects, and cardiovascular medication overlap.
Telemedicine Monitoring Protocols for At-Home Ketamine Therapy
How are patients monitored during at-home low-dose ketamine sessions? Review of remote vitals, observer protocols, video check-ins, and safety frameworks.
Contraindications and Screening Protocols for Ketamine Therapy
A thorough guide to absolute and relative contraindications for low-dose ketamine, along with recommended screening protocols encompassing medical history, psychiatric evaluation, laboratory assessment, and informed consent procedures.
Geriatric Considerations in Low-Dose Ketamine Therapy
Is ketamine therapy safe for elderly patients? Review of age-related pharmacokinetics, cardiovascular risk, cognitive monitoring, and low-dose adjustments.
Contact Low Dose Ketamine
Send corrections, provider questions, or advertising inquiries.